Clinical Trial Update: Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating vorinostat for progressive metastatic prostate cancer has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Vorinostat (Zolinza) (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Prostate Cancer, Stage IV Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-05-26